Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,069 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Recruiting

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

NCT06780085

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Kentucky Chandler Medical Center ( Site 0019) Lexington, Kentucky, United States
  • MedStar Franklin Square Medical Center ( Site 0033) Baltimore, Maryland, United States
  • AHN Cancer Institute - Allegheny General ( Site 9501) Pittsburgh, Pennsylvania, United States
  • Centro de Estudios Clínicos SAGA ( Site 0161) Santiago, Region M. de Santiago, Chile
View all 34 locations
View Trial Details
Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

NCT05498428

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of California at San Diego La Jolla, California, United States
  • University of California Irvine Orange, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 110 locations
View Trial Details
Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

NCT07300150

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +24 more
Locations
  • Dana-Farber/Massachusetts General Hospital, Inc Boston, Massachusetts, United States
  • New Experimental Therapeutics of San Antonio LLC San Antonio, Texas, United States
  • START - South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View Trial Details
Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

NCT06667908

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Moores Cancer Center at UC San Diego Health La Jolla, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
View all 43 locations
View Trial Details
Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • START New York Long Island Lake Success, New York, United States
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
View Trial Details

Related conditions